Reading between the lines in the MD&A 1Q26: Wattanapat Hospital Trang Public Company Limited (WPH)
Reading between the lines in the 1Q26 Management Discussion and Analysis of Wattanapat Hospital Trang Public Company Limited (WPH): Revenue up 10.4%. Net profit up 3.3%. And a hospital that opened in March 2026, with no name in the prior filing.
The numbers
International patients cross 50% of revenue for the first time
Wattanapat Hospital Trang operates a private hospital group in southern Thailand, with its parent facility in Trang and subsidiaries in Ao Nang and Samui. In 1Q26, total revenue rose 10.4% YoY to Bt800m, driven by a 23.3% YoY surge in international patient revenue to Bt451m. International patients accounted for 57% of medical revenue in 1Q26, up from 51% in 1Q25. Thai patient revenue contracted 2.7% YoY to Bt346m.
Costs outpace revenue; margins compress
Gross margin fell to 41.5% in 1Q26 from 42.5% in 1Q25, as cost of medical treatment rose 12.4% against revenue growth of 10.4%, driven by doctor fees, personnel expenses, and depreciation. SG&A rose 23.1% YoY, partly from sales promotion expenses linked to international patient growth and partly from Bt12m of pre-operating and launch costs for two new subsidiary openings. Net profit grew 3.3% to Bt188m, a net margin of 23.5% against 25.1% in 1Q25.
Assets rise on new hospital construction
Total assets rose 6.7% to Bt3,822m from Bt3,582m at FY25, driven by land acquisitions and construction across two new hospital projects, including Wattanapat Phuket Hospital, scheduled to open in October 2026. Total liabilities rose 3.8% to Bt1,595m, reflecting long-term loan drawdowns by a subsidiary to fund that construction.
What the numbers don’t show
Comparing the 4Q25 MD&A with 1Q26, a couple of things stand out.
Koon Wattanapat Hospital opened in March 2026, but is unnamed in the FY25 filing
The 4Q25 MD&A disclosed pre-operating costs of Bt7m in 4Q25 and Bt16m for the full year 2025, attributed to staffing and setup expenses for “two new subsidiaries” scheduled to open in 2026. The only subsidiary named in the FY25 filing in this context is Wattanapat Phuket Hospital, in the equity section. The 1Q26 MD&A discloses that Koon Wattanapat Hospital commenced operations in mid-March 2026, identifying it as one of the two subsidiaries for which pre-operating costs were being incurred throughout 2025. A hospital that opened within the filing quarter was not named, located, or described anywhere in the prior filing, despite Bt16m in costs already recorded against its preparation.
The international patient narrative has inverted between the two filings
The 4Q25 MD&A’s industry section forecast international patient revenue growth of 4.3% for the Thai private hospital sector in 2026, with Scandinavian long-stay visitors highlighted as a high-potential growth segment. It also noted a significant uptick in patients from the Middle East in the latter half of FY25, representing a new source of international revenue growth. In 1Q26, both cohorts reappear with the opposite framing: Scandinavian and European patients are identified as having delayed travel for medical services due to geopolitical flight disruptions, and the Middle East is named as a core market under pressure from the Iran-US situation. The company describes the 1Q26 impact as “limited” and “temporary,” but neither patient segment is described as a growth contributor in 1Q26.